Press Releases May 20, 2026 04:05 PM

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

Tactile Medical to present at William Blair 46th Annual Growth Stock Conference in June 2026

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
TCMD

Tactile Systems Technology, Inc., a leader in at-home therapies for chronic conditions, announced its management will present at the William Blair 46th Annual Growth Stock Conference in Chicago from June 2-4, 2026. The presentation will be webcast live and archived afterwards for investor access.

Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference
TCMD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Tactile Medical specializes in at-home therapies for chronic disorders such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease.
  • The company aims to improve patient quality of life while reducing overall healthcare costs through home-based treatment solutions.
  • Participation in a prestigious growth stock conference highlights ongoing investor engagement and company visibility in the healthcare sector.

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 46th Annual Growth Stock Conference, which is being held at the Loews Hotel in Chicago, IL, from June 2-4, 2026. Management will present on Tuesday, June 2, at 9:20 a.m. Central Time.

A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.

About Tactile Systems Technology, Inc. (DBA Tactile Medical)

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com


Risks

  • The company operates in a niche market that may face reimbursement and regulatory uncertainties impacting growth.
  • Dependence on clinical evidence and clinician collaboration means any setback in these areas could affect product adoption.
  • Market competition from other medical technology firms could pressure market share and margins.

More from Press Releases

Applied Digital Announces Proposed Offering of $1.59 Billion of Senior Secured Notes to fund the Fourth Building at Polaris Forge 1 Jun 9, 2026 VEON Appoints Serkan Ozturk as Chief of Staff & Strategy Officer Jun 9, 2026 PureCycle, Innovia Films Partner to Successfully Produce White, Cavitated BOPP Film Using PureFive Choice™ Recycled Polypropylene Jun 9, 2026 BitFuFu Announces May 2026 Bitcoin Production and Operational Updates Jun 9, 2026 ZenaTech Added to Russell 3000® Index, Marking Major Milestone in Company's Growth and Market Recognition Jun 9, 2026